Could YOU make the move?

What was good about pharma sales? “For me it was the initial training programme that the companies put you through.” Geran recalled; “It is...

The NHIS Update

The NHIS update is intended to give a monthly overview of some key issues affecting the NHS. Full access to the...

Selling a Superbrand

There’s no doubt about it: Viagra® (sildenafil) is one of the most instantly recognisable brands in the pharmaceutical market. This month, Pf looks at...

ABPI

Pre-budget report: ABPI response Two initiatives that will boost the UK’s research and development effort, announced in the Chancellor of the Exchequer’s Pre-Budget Report,...

Pharma-logically Speaking! (Part 2)

I have come to realise that many ‘discussions’ around a sales call come down to ‘beliefs’. And to ‘effect change in one’s beliefs’ relies...

The New PPRS Agreement

THE NEW PPRS scheme (Prescription Price Regulatory Scheme) comes into force from the 1st January 2005 with the aim of reducing the cost of...

Thank You – This is all About You: A people Orientated Sector

Culture . . . Does it make a difference? Is the culture of your company unique? Are you amongst the best and are you...

Movements in the NHS: Hospital to Alternate Site

By Gordon Blackwell, The National Health Intelligence Service Whenever possible, patient care is being moved away from hospitals into the community, so that, within...

Sales, Sales and More Sales Please – An Accountable Sector

WHY DID YOU join the industry and become a sales person? Was it to sell through managing your own territory and influencing prescribers, or...

High cost of new Cancer drugs too high for some?

The world’s aging population is expected to facilitate a 50% increase in the global incidence of cancer over the next two decades, with the...

Latest articles

Logo for Atrial Fibrillation Toolkit: Tackling avoidable strokes to save lives and strain on the NHS

Atrial Fibrillation Toolkit: Tackling avoidable strokes to save lives and strain on the NHS

The AHSN Network of 15 Academic Health Science Networks in England has launched the national ‘Atrial Fibrillation Toolkit’ (www.aftoolkit.co.uk) to address barriers to stroke...
Image of a person presenting data to show Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis

Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis

Novartis announces publication of Phase III ASCLEPIOS trials data in NEJM demonstrating efficacy of the ofatumumab in patients with relapsing multiple sclerosis. Novartis has announced...
Image of business people nurturing plants growing with light bulbs at the top to show Primary care networks and mental health services post COVID-19

Primary care networks and mental health services post COVID-19

Joint working between primary care networks and providers of mental health services must accelerate if the NHS is to help the huge increase in...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Woman with mask on phone: use of electronic prescribing

Accelerated use of electronic prescribing

Deborah Evans, Managing Director of Pharmacy Complete, looks at the instruction to stay at home, GP surgeries closing their doors and consumers rethinking how...
Image of a person presenting data to show Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis

Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis

Novartis announces publication of Phase III ASCLEPIOS trials data in NEJM demonstrating efficacy of the ofatumumab in patients with relapsing multiple sclerosis. Novartis has announced...
Meeting on ipad: COVID-19 pharma workforce

COVID-19: changing the pharma workforce

There’s no denying the COVID-19 has changed the world, but will it have a lasting effect on the pharma workforce? Graham Hawthorn Managing Director, CHASE It is...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription